Journal article · 2026 · Open access

Validation of clinical and preclinical obesity across global cohorts

An Pan, Shengping Yang, Rafael Ramos, Xianli Li, Jinchi Xie, Robert H. Eckel, Geltrude Mingrone, Jordi Blanch, Jingyuan Jiang, Hongmin Liu, Shuohua Chen, Tingting Geng and 4 more

Nature · Published 11 November 2026 · DOI 10.1038/s41586-026-11237-5

Open PDFView at the publisherCite this paper

In brief

“Validation of clinical and preclinical obesity across global cohorts” is a 2026 journal article by An Pan and 15 co-authors, published in Nature. OpenAlex counts 2 citations as of 18 November 2026, which puts it in the top 6% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Nature.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
7.55
References
24
Authors
16

Abstract

In 2025, a Lancet Commission proposed distinguishing clinical obesity, defined by adiposity-related organ dysfunction, from preclinical obesity, defined by excess adiposity with preserved function, and recommended using anthropometric measures beyond body mass index (BMI) to confirm obesity status 1 . Here we report the comparative performance of this framework versus conventional BMI-based classification using prevalence, incidence and mortality data from 844,108 adults across four cohorts in China, the UK, the USA and Spain. Complementing BMI with waist circumference and waist-to-height ratio data showed that BMI alone overestimated obesity in 1.2–3.1% and underestimated it in 5.2–8.6% of participants across cohorts. The combined anthropometric definition increased overall obesity prevalence by 3.3–7.4% relative to BMI-based classification. Clinical obesity accounted for 22.7–31.3% of total obesity, with an overall population prevalence of 5.6–10.9%. A large proportion of individuals (between 77.4% and 91.3%) with preclinical obesity at baseline showed no progression to clinical obesity over 10 years. Increased mortality risk was associated with the combined anthropometric definition of obesity, but not with BMI-only obesity. Clinical obesity was associated with substantially higher all-cause mortality (hazard ratio 1.69, 95% confidence interval 1.64–1.73), whereas preclinical obesity conferred only modest risk (1.19, 1.14–1.24). These findings support the global adoption of the Lancet Commission diagnostic framework to improve obesity care and policy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Pan, A., Yang, S., Ramos, R., Li, X., Xie, J., Eckel, R. H., Mingrone, G., Blanch, J., Jiang, J., Liu, H., Chen, S., Geng, T., Wu, S., Ravussin, É., Fernández‐Real, J. M., & Rubino, F. (2026). Validation of clinical and preclinical obesity across global cohorts. Nature. https://doi.org/10.1038/s41586-026-11237-5

MLA 9

Pan, An, et al. “Validation of clinical and preclinical obesity across global cohorts.” Nature, 2026. https://doi.org/10.1038/s41586-026-11237-5.

Chicago

Pan, An, Shengping Yang, Rafael Ramos, Xianli Li, Jinchi Xie, Robert H. Eckel, Geltrude Mingrone, et al. 2026. “Validation of clinical and preclinical obesity across global cohorts.” Nature. https://doi.org/10.1038/s41586-026-11237-5.

Harvard

Pan, A. et al. (2026) ‘Validation of clinical and preclinical obesity across global cohorts’, Nature. doi:10.1038/s41586-026-11237-5.

IEEE

A. Pan et al., “Validation of clinical and preclinical obesity across global cohorts,” Nature, 2026, doi: 10.1038/s41586-026-11237-5.

BibTeX

@article{pan2026validation,
  title     = {{Validation of clinical and preclinical obesity across global cohorts}},
  author    = {Pan, An and Yang, Shengping and Ramos, Rafael and Li, Xianli and Xie, Jinchi and Eckel, Robert H. and Mingrone, Geltrude and Blanch, Jordi and Jiang, Jingyuan and Liu, Hongmin and Chen, Shuohua and Geng, Tingting and Wu, Shouling and Ravussin, Éric and Fernández‐Real, José Manuel and Rubino, Francesco},
  journal   = {Nature},
  year      = {2026},
  doi       = {10.1038/s41586-026-11237-5},
  url       = {https://doi.org/10.1038/s41586-026-11237-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet

  • clinical obesity
  • preclinical obesity
  • obesity classification
  • body mass index
  • waist circumference
  • waist-to-height ratio
  • anthropometric measures
  • obesity prevalence

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Pan, A., Yang, S., Ramos, R., Li, X., Xie, J., Eckel, R. H., Mingrone, G., Blanch, J., Jiang, J., Liu, H., Chen, S., Geng, T., Wu, S., Ravussin, É., Fernández‐Real, J. M., & Rubino, F. (2026). Validation of clinical and preclinical obesity across global cohorts. Nature. https://doi.org/10.1038/s41586-026-11237-5

How many times has this paper been cited?

2 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature: sign in and open the PDF from this page.

Who wrote this paper?

An Pan, Shengping Yang, Rafael Ramos, Xianli Li, Jinchi Xie, Robert H. Eckel, Geltrude Mingrone, Jordi Blanch, Jingyuan Jiang, Hongmin Liu, Shuohua Chen, Tingting Geng and 4 more.

What is the DOI of this paper?

10.1038/s41586-026-11237-5, permanently at https://doi.org/10.1038/s41586-026-11237-5. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.